Standard of Care Surgery + NIVOLUMAB + IPILIMUMAB for head and neck neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Sep 2016: Trial registered, NCT02919683

The trials

NCT02919683: Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity

State
Under way
Phase
Phase 2
People
30 taking part
Started
Nov 2016
Primary completion
Jul 2019
Arms
Nivolumab With Ipilimumab
Results
Posted on the registry
  1. 29 Sep 2016: Trial registered
  2. 31 Jul 2020: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.